Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Leukemia
|
March 1, 1997
Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations
K Tanaka, M Arif, M Eguchi, et al.
Cancer Genetics and Cytogenetics
|
February 13, 2001
Restricted chromosome breakpoint sites on 11q22-q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangement
K Tanaka, M Eguchi, M Eguchi-Ishimae, et al.
British Journal of Haematology
|
June 3, 1999
Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain
M Shikami, H Miwa, K Nishii, et al.
Blood
|
June 1, 1996
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
T Miyamoto, K Nagafuji, K Akashi, et al.
Leukemia
|
July 3, 2002
Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia
K Nishii, N Katayama, H Miwa, et al.
Leukemia
|
January 6, 2007
Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis
K Nakase, K Kita, H Miwa, et al.
Leukemia
|
December 14, 2011
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A Tsuboi, Y Oka, T Kyo, et al.
International Journal of Hematology
|
May 22, 1998
Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
S Kawamura, R Ueda, R Ohno, et al.
Blood
|
September 15, 1996
Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels
K Inoue, H Ogawa, T Yamagami, et al.
Leukemia
|
April 12, 2003
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML
K Nishii, E Usui, N Katayama, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Leukemia
|
March 1, 1997
Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations
K Tanaka, M Arif, M Eguchi, et al.
Cancer Genetics and Cytogenetics
|
February 13, 2001
Restricted chromosome breakpoint sites on 11q22-q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangement
K Tanaka, M Eguchi, M Eguchi-Ishimae, et al.
British Journal of Haematology
|
June 3, 1999
Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain
M Shikami, H Miwa, K Nishii, et al.
Blood
|
June 1, 1996
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
T Miyamoto, K Nagafuji, K Akashi, et al.
Leukemia
|
July 3, 2002
Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia
K Nishii, N Katayama, H Miwa, et al.
Leukemia
|
January 6, 2007
Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis
K Nakase, K Kita, H Miwa, et al.
Leukemia
|
December 14, 2011
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A Tsuboi, Y Oka, T Kyo, et al.
International Journal of Hematology
|
May 22, 1998
Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
S Kawamura, R Ueda, R Ohno, et al.
Blood
|
September 15, 1996
Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels
K Inoue, H Ogawa, T Yamagami, et al.
Leukemia
|
April 12, 2003
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML
K Nishii, E Usui, N Katayama, et al.
Page
of 7